Drug Discovery


Drug Discovery Market Research Reports Analysis and Trends

Publication Single User License (PDF) Price
Nonalcoholic Steatohepatitis (NASH) - Pipeline Analysis

Nonalcoholic Steatohepatitis (NASH) - Pipeline Analysis

Date Published: Jul 17 2015
 “Nonalcoholic steatohepatitis (NASH) Pipeline Analysis” gives comprehensive insight on the various drugs being developed for the treatment of NASH. The report covers all the drugs being developed in various phases (Discovery, Preclinical & Clinical development). The pipeline focuses on novel medicines covering small molecules, monoclonal antibodies, Recombinant proteins and RNA-based therapeutics, but excludes Off-label, symptom relief drugs, generic combinations.
$3,600.00
Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015

Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2015

Date Published: Jul 1 2015
$1,750.00
 Acute Promyelocytic Leukemia-Pipeline Insights, 2015

Acute Promyelocytic Leukemia-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Acute Promyelocytic Leukemia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Acute Promyelocytic Leukemia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Acute Promyelocytic Leukemia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Mycosis Fungoides-Pipeline Insights, 2015

Mycosis Fungoides-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Mycosis Fungoides- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Mycosis Fungoides. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Mycosis Fungoides Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Blood Coagulation Factor Inhibitors -Pipeline Insights, 2015

Blood Coagulation Factor Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Blood Coagulation Factor Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Blood Coagulation Factor Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Blood Coagulation Factor Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Plasminogen Activator Inhibitors -Pipeline Insights, 2015

Plasminogen Activator Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Plasminogen Activator Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Plasminogen Activator Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Plasminogen Activator Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Growth Hormone Deficiency-Pipeline Insights, 2015

Growth Hormone Deficiency-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Growth Hormone Deficiency- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Growth Hormone Deficiency. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Growth Hormone Deficiency Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Venous Leg Ulcers-Pipeline Insights, 2015

Venous Leg Ulcers-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Venous Leg Ulcers- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Venous Leg Ulcers. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Venous Leg Ulcers Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Interleukin-16 (IL-16) Inhibitors -Pipeline Insights, 2015

Interleukin-16 (IL-16) Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Interleukin-16 (IL-16) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Interleukin-16 (IL-16) Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Interleukin-16 (IL-16) Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Cedar Pollen Allergy-Pipeline Insights, 2015

Cedar Pollen Allergy-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Cedar Pollen Allergy- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Cedar Pollen Allergy. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Cedar Pollen Allergy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Post Menopausal Osteoporosis-Pipeline Insights, 2015

Post Menopausal Osteoporosis-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Post Menopausal Osteoporosis- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Post Menopausal Osteoporosis. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Post Menopausal Osteoporosis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
DNA Polymerase Beta Inhibitors -Pipeline Insights, 2015

DNA Polymerase Beta Inhibitors -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, DNA Polymerase Beta Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the DNA Polymerase Beta Inhibitors. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The DNA Polymerase Beta Inhibitors Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
TGR5 Receptor Agonists -Pipeline Insights, 2015

TGR5 Receptor Agonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, TGR5 Receptor Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the TGR5 Receptor Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The TGR5 Receptor Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Liposarcoma -Pipeline Insights, 2015

Liposarcoma -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Liposarcoma - Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Liposarcoma . The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Liposarcoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Androgen Antagonists -Pipeline Insights, 2015

Androgen Antagonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Androgen Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Androgen Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Androgen Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
Neuropeptide Y Receptor Y4 (NPY4R) Agonists -Pipeline Insights, 2015

Neuropeptide Y Receptor Y4 (NPY4R) Agonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Neuropeptide Y Receptor Y4 (NPY4R) Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Neuropeptide Y Receptor Y4 (NPY4R) Agonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neuropeptide Y Receptor Y4 (NPY4R) Agonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Enterococcus Infections-Pipeline Insights, 2015

Enterococcus Infections-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Enterococcus Infections- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Enterococcus Infections. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Enterococcus Infections Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Soft Tissue Sarcoma-Pipeline Insights, 2015

Soft Tissue Sarcoma-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Soft Tissue Sarcoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Soft Tissue Sarcoma. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Soft Tissue Sarcoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
G-Protein Coupled Receptor (GPCR) Antagonists -Pipeline Insights, 2015

G-Protein Coupled Receptor (GPCR) Antagonists -Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, G-Protein Coupled Receptor (GPCR) Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the G-Protein Coupled Receptor (GPCR) Antagonists. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The G-Protein Coupled Receptor (GPCR) Antagonists Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00
 Angioedema-Pipeline Insights, 2015

Angioedema-Pipeline Insights, 2015

Date Published: May 14 2015

Summary
DelveInsight’s, Angioedema- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Angioedema. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Angioedema Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

$1,250.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakP&G, Cisco, Gemalto, General Insurance Corporation of India, Aviva, Cognizant, InoxWindB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data